幽门螺杆菌
疾病
背景(考古学)
医学
无症状的
免疫学
免疫系统
消化性溃疡
炎症
入射(几何)
生物信息学
胃肠病学
生物
内科学
古生物学
物理
光学
作者
Gaurav Doshi,Alveera Ansari,Nirav Bhatia,Sankalp Gharat,Angel Godad
出处
期刊:Endocrine, metabolic & immune disorders
[Bentham Science Publishers]
日期:2022-08-30
卷期号:23 (1): 21-34
被引量:6
标识
DOI:10.2174/1871530322666220829142124
摘要
Abstract: Peptic ulcer disease (PUD) is a widespread condition that affects millions of people each year, with an incidence rate of 0.1%-1.5%, and has a significant impact on human health. A range of stimuli, such as Helicobacter pylori, non-steroidal anti-inflammatory drugs, hyperacidity, stress, alcohol, smoking, and idiopathic disease states, can produce a sore in the gastrointestinal mucosal layer. For individuals infected with H. pylori, 2%-3% remain asymptomatic throughout their life. Although PUD treatments are available, genetic variations occurring in individuals because of geographical dissimilarity and antibiotic resistance pose limitations. Specifically, inflammatory cytokine gene polymorphisms have received immense attention in recent years because they appear to affect the severity and duration of stomach inflammation, which is induced by H. pylori infection, contributing to the initiation of PUD. In such a context, in-depth knowledge of interleukins may aid in the discovery of new targets and provide precautionary approaches for the treatment of PUD. This review aims to give insights into the importance of several interleukins that cognate with PUD and contribute to ulcer progression or healing by activating or dampening the host immunity. Furthermore, the available targets with clinical evidence have been explored in this review.
科研通智能强力驱动
Strongly Powered by AbleSci AI